_version_ 1784635473522589696
author Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Tipples, Graham
Sharifi, Nastaran
van Huyssteen, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bindra, Gurmeet
Mahoney, Douglas
Ingram, Richard
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph
Buie, Michael
Chan, Melissa
Ferraz, Jose
Lu, Cathy
Mathivanan, Meena
Novak, Kerri
Seow, Cynthia
Shukla, Tushar
Kaplan, Gilaad
author_facet Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Tipples, Graham
Sharifi, Nastaran
van Huyssteen, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bindra, Gurmeet
Mahoney, Douglas
Ingram, Richard
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph
Buie, Michael
Chan, Melissa
Ferraz, Jose
Lu, Cathy
Mathivanan, Meena
Novak, Kerri
Seow, Cynthia
Shukla, Tushar
Kaplan, Gilaad
author_sort Quan, Joshua
collection PubMed
description
format Online
Article
Text
id pubmed-8770895
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-87708952022-01-20 SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY Quan, Joshua Ma, Christopher Panaccione, Remo Kanji, Jamil Tipples, Graham Sharifi, Nastaran van Huyssteen, Michelle Markovinovic, Ante Turnbull, LeeAnn Bindra, Gurmeet Mahoney, Douglas Ingram, Richard Hracs, Lindsay Coward, Stephanie Windsor, Joseph Buie, Michael Chan, Melissa Ferraz, Jose Lu, Cathy Mathivanan, Meena Novak, Kerri Seow, Cynthia Shukla, Tushar Kaplan, Gilaad Gastroenterology Epidemiology Published by Elsevier Inc. 2022-02 2022-01-20 /pmc/articles/PMC8770895/ http://dx.doi.org/10.1053/j.gastro.2021.12.098 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Epidemiology
Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Tipples, Graham
Sharifi, Nastaran
van Huyssteen, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bindra, Gurmeet
Mahoney, Douglas
Ingram, Richard
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph
Buie, Michael
Chan, Melissa
Ferraz, Jose
Lu, Cathy
Mathivanan, Meena
Novak, Kerri
Seow, Cynthia
Shukla, Tushar
Kaplan, Gilaad
SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_full SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_fullStr SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_full_unstemmed SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_short SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_sort serological responses to sars-cov-2 vaccination in patients with inflammatory bowel disease: a prospective cohort study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770895/
http://dx.doi.org/10.1053/j.gastro.2021.12.098
work_keys_str_mv AT quanjoshua serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT machristopher serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT panaccioneremo serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT kanjijamil serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT tipplesgraham serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT sharifinastaran serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT vanhuyssteenmichelle serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT markovinovicante serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT turnbullleeann serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT bindragurmeet serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT mahoneydouglas serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT ingramrichard serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT hracslindsay serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT cowardstephanie serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT windsorjoseph serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT buiemichael serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT chanmelissa serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT ferrazjose serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT lucathy serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT mathivananmeena serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT novakkerri serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT seowcynthia serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT shuklatushar serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT kaplangilaad serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy